Cost-effectiveness in oncology

Lancet. 1985 Dec;2(8469-8470):1405-8.

Abstract

KIE: A 1984 report of a British Working Group on Acute Services for Cancer offered guidance to the National Health Service (NHS) on the effective use of resources to achieve maximum benefit for cancer patients. Rees discusses the need to consider the cost effectiveness of these resources. He presents an analysis of the costs of various diagnostic, treatment, and related care modalities in relation to the quality of life achieved, showing that palliative care is considerably more expensive than curative treatment. Rees maintains that these higher costs can be assumed by a compassionate society until they result in an inequitable distribution of resources. He proposes strategies for cost containment based on greater general practitioner and patient involvement, reduction of inpatient care and marginally beneficial follow-up and testing, restriction of the more expensive drugs to curative treatment, and greater use of hospice services.

MeSH terms

  • Biomedical Technology
  • Cost-Benefit Analysis*
  • Delivery of Health Care*
  • Economics*
  • Evaluation Studies as Topic*
  • General Surgery
  • Health Care Rationing*
  • Hospices
  • Hospitals
  • Humans
  • National Health Programs*
  • Neoplasms*
  • Palliative Care
  • Patient Care*
  • Patient Selection
  • Pharmaceutical Preparations
  • Quality of Life
  • Radiology
  • Research
  • Resource Allocation*
  • Risk
  • Risk Assessment
  • Statistics as Topic
  • Terminal Care
  • Therapeutic Human Experimentation
  • United Kingdom
  • Value of Life

Substances

  • Pharmaceutical Preparations